Locations
Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
201-1000 employees
Stage
Other
founded in
2019
Prime Medicine is a biotechnology company focused on transforming the lives of patients with debilitating diseases through its innovative Prime Editing technology. This next-generation gene editing platform aims to address the genetic causes of diseases, offering potentially long-lasting cures by precisely editing faulty DNA sequences. With the ability to theoretically target about 90% of known disease-causing mutations, Prime Editing is designed to work efficiently across various genetic mutations while minimizing unwanted modifications. The company is positioned to significantly impact the gene editing landscape, with a commitment to developing one-time curative therapies for a wide spectrum of diseases.
Something looks off?